In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

被引：2
|
作者：
Awar, Melina [1 ]
Mylonakis, Eleftherios [1 ]
机构：
[1] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 06期
关键词：
D O I：
10.7326/J23-0039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Source Citation Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161 Clinical Impact Ratings GIM/FP/GP: GIM/FP/GP: Geriatrics: Infectious Disease: Pulmonology: Public Health:
引用
收藏
页码：JC63 / JC63
页数：1
相关论文
共 50 条
  • [31] Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial
    Jastorff, Archana
    Gymnopoulou, Efi
    Salas, Jose
    Merrall, Elizabeth
    Buntinx, Erik
    Martin, Charlotte
    Askling, Helena H.
    Schenkenberger, Isabelle
    Yuste, Angela Cano
    Smith, William
    Sotolongo, Roberto
    Von Engelhardt, Charlotte
    Bastian, Arangassery Rosemary
    Comeaux, Christy
    Ligtenberg, Nynke
    Callendret, Benoit
    Heijnen, Esther
    VACCINE, 2025, 43
  • [32] Potential Impact of Nirsevimab on RSV Transmission and Medically Attended Lower Respiratory Tract Illness Caused by RSV: A Disease Transmission Model
    Nicolas Voirin
    Victor Virlogeux
    Clarisse Demont
    Alexia Kieffer
    Infectious Diseases and Therapy, 2022, 11 : 277 - 292
  • [33] Potential Impact of Nirsevimab on RSV Transmission and Medically Attended Lower Respiratory Tract Illness Caused by RSV: A Disease Transmission Model
    Voirin, Nicolas
    Virlogeux, Victor
    Demont, Clarisse
    Kieffer, Alexia
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (01) : 277 - 292
  • [34] Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
    Walsh, Edward E.
    Eiras, Daniel
    Woodside, John
    Jiang, Qin
    Patton, Michael
    Marc, Gonzalo Perez
    Llapur, Conrado
    Ramet, Mika
    Fukushima, Yasushi
    Hussen, Nazreen
    Cardona, Jose
    Mikati, Tarek
    Zareba, Agnieszka
    Ilangovan, Kumar
    Lino, Maria Maddalena
    Kalinina, Elena, V
    Swanson, Kena A.
    Gurtman, Alejandra
    Munjal, Iona
    RENOIR Clin Trial Grp
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [35] Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
    Ison, Michael G.
    Papi, Alberto
    Athan, Eugene
    Feldman, Robert G.
    Langley, Joanne M.
    Lee, Dong-Gun
    Leroux-Roels, Isabel
    Martinon-Torres, Federico
    Schwarz, Tino F.
    van Zyl-Smit, Richard N.
    Verheust, Celine
    Dezutter, Nancy
    Gruselle, Olivier
    Fissette, Laurence
    David, Marie-Pierre
    Kostanyan, Lusine
    Hulstrom, Veronica
    Olivier, Aurelie
    van der Wielen, Marie
    Descamps, Dominique
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (06) : 1732 - 1744
  • [36] Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
    Fries, Louis
    Shinde, Vivek
    Stoddard, Jeffrey J.
    Thomas, D. Nigel
    Kpamegan, Eloi
    Lu, Hanxin
    Smith, Gale
    Hickman, Somia P.
    Piedra, Pedro
    Glenn, Gregory M.
    IMMUNITY & AGEING, 2017, 14
  • [37] Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
    Louis Fries
    Vivek Shinde
    Jeffrey J. Stoddard
    D. Nigel Thomas
    Eloi Kpamegan
    Hanxin Lu
    Gale Smith
    Somia P. Hickman
    Pedro Piedra
    Gregory M. Glenn
    Immunity & Ageing, 14
  • [38] Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
    Panozzo, Catherine A.
    Walsh, Edward E.
    Yang, Zhen
    Wilson, Eleanor
    Goswami, Jaya
    Stoszek, Sonia K.
    Loback, Adrianna
    Ng, Tony
    Francis, Beverly M.
    Simorellis, Alana K.
    Huang, Wenmei
    Li, Linwei
    Vislay-Wade, Rebecca
    Zheng, Zhe
    Anderson, Evan J.
    August, Allison
    Chen, Grace
    Falsey, Ann R.
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (01) : 275 - 281
  • [39] Recombinant respiratory syncytial virus (RSV) vaccine for older adults, and pregnant women to prevent disease in their infant
    不详
    AUSTRALIAN PRESCRIBER, 2024, 47 (03) : 100 - 101
  • [40] Nirsevimab for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and Infants
    不详
    AUSTRALIAN PRESCRIBER, 2024, 47 (03) : 102 - 103
12345